Medpace Holdings (NASDAQ: MEDP) reported Q3 EPS of $0.67, $0.05 better than the analyst estimate of $0.62. Revenue for the quarter came in at $179.3 million versus the consensus estimate of $175.28 million.

GUIDANCE:

Medpace Holdings sees FY2018 EPS of $2.76-$2.82, versus the consensus of $2.42.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.